Nyxthracis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nyxthracis, covering 2024-09-09 to 2024-09-09. Get the full timeline:
Most recent: EMA Withdrawn: Nyxthracis (previously Obiltoxaximab SFL) (nyxthracis) — SFL Pharmaceuticals Deutschland GmbH